Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
35
Number of overlapping holdings
17.4%
% of IBB's 219 holdings also in IDNA
74.5%
% of IDNA's 51 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 8.2% | 4.3% | 4.3% |
|
MODERNA, INC. | 3.7% | 5.0% | 3.7% |
|
GILEAD SCIENCES INC | 8.2% | 3.4% | 3.4% |
 |
BIONTECH SE SPONSORED ADR | 1.9% | 3.4% | 1.9% |
|
INCYTE CORP | 1.3% | 3.8% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to IDNA
|
AMGEN INC | 8.7% |
|
VERTEX PHARMACEUTICALS INC | 8.3% |
|
GILEAD SCIENCES INC | 4.9% |
|
IQVIA HOLDINGS INC | 4.4% |
|
REGENERON PHARMACEUTICALS | 3.9% |
|
BIOGEN IDEC INC | 3.0% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.7% |
|
ILLUMINA INC | 2.0% |
|
ALNYLAM PHARMACEUTICALS INC | 2.0% |
 |
ARGENX SE ADR | 2.0% |
IBB Underweight Relative to IDNA
|
REVOLUTION MEDICINES, INC. | -5.1% |
|
MERCK & CO. INC. | -4.7% |
|
SAREPTA THERAPEUTICS INC | -4.2% |
 |
SANOFI-AVENTIS | -3.9% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -3.6% |
 |
GENMAB A/S | -3.6% |
|
ROCHE HOLDING LTD | -3.5% |
|
EXELIXIS INC | -3.3% |
 |
BEIGENE, LTD. | -3.1% |
|
IOVANCE BIOTHERAPEUTICS INC | -2.8% |